<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34069857</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5292</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22105292</ELocationID><Abstract><AbstractText>The number of patients with neurodegenerative diseases (NDs) is increasing, along with the growing number of older adults. This escalation threatens to create a medical and social crisis. NDs include a large spectrum of heterogeneous and multifactorial pathologies, such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple system atrophy, and the formation of inclusion bodies resulting from protein misfolding and aggregation is a hallmark of these disorders. The proteinaceous components of the pathological inclusions include several RNA-binding proteins (RBPs), which play important roles in splicing, stability, transcription and translation. In addition, RBPs were shown to play a critical role in regulating miRNA biogenesis and metabolism. The dysfunction of both RBPs and miRNAs is often observed in several NDs. Thus, the data about the interplay among RBPs and miRNAs and their cooperation in brain functions would be important to know for better understanding NDs and the development of effective therapeutics. In this review, we focused on the connection between miRNAs, RBPs and neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinoshita</LastName><ForeName>Chisato</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5877-0196</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Teikyo University Support Center for Women Physicians and Researchers, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoyama</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A</GrantID><Agency>Naito Science and Engineering Foundation</Agency><Country/></Grant><Grant><GrantID>A</GrantID><Agency>Teikyo University School of Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA-binding protein</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34069857</ArticleId><ArticleId IdType="pmc">PMC8157344</ArticleId><ArticleId IdType="doi">10.3390/ijms22105292</ArticleId><ArticleId IdType="pii">ijms22105292</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dugger B.N., Dickson D.W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 2017;9:a028035. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao J.-Y., Yang B., Zhang Y.-C., Wang X.-J., Ye Y., Peng J.-W., Yang Z.-Z., He J.-H., Zhang Y., Hu K., et al. EuRBPDB: A comprehensive resource for annotation, functional and oncological investigation of eukaryotic RNA binding proteins (RBPs) Nucleic Acids Res. 2020;48:D307&#x2013;D313. doi: 10.1093/nar/gkz823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz823</ArticleId><ArticleId IdType="pmc">PMC6943034</ArticleId><ArticleId IdType="pubmed">31598693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerstberger S., Hafner M., Tuschl T. A census of human RNA-binding proteins. Nat. Rev. Genet. 2014;15:829&#x2013;845. doi: 10.1038/nrg3813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3813</ArticleId><ArticleId IdType="pubmed">25365966</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerner P., Degnan S.M., Marchand L., Degnan B.M., Vervoort M. Evolution of RNA-binding proteins in animals: Insights from genome-wide analysis in the sponge Amphimedon queenslandica. Mol. Biol. Evol. 2011;28:2289&#x2013;2303. doi: 10.1093/molbev/msr046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msr046</ArticleId><ArticleId IdType="pubmed">21325094</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson M.R. RNA-binding proteins implicated in neurodegenerative diseases. Wiley Interdiscip. Rev. RNA. 2017;8 doi: 10.1002/wrna.1397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1397</ArticleId><ArticleId IdType="pmc">PMC5179305</ArticleId><ArticleId IdType="pubmed">27659605</ArticleId></ArticleIdList></Reference><Reference><Citation>Glisovic T., Bachorik J.L., Yong J., Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008;582:1977&#x2013;1986. doi: 10.1016/j.febslet.2008.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.03.004</ArticleId><ArticleId IdType="pmc">PMC2858862</ArticleId><ArticleId IdType="pubmed">18342629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B., Ivanov P. Stress granules and neurodegeneration. Nat. Rev. Neurosci. 2019;20:649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Na Z., Slavoff S.A. P-Bodies: Composition, properties, and functions. Biochemistry. 2018;57:2424&#x2013;2431. doi: 10.1021/acs.biochem.7b01162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.7b01162</ArticleId><ArticleId IdType="pmc">PMC6296482</ArticleId><ArticleId IdType="pubmed">29381060</ArticleId></ArticleIdList></Reference><Reference><Citation>Advani V.M., Ivanov P. Stress granule subtypes: An emerging link to neurodegeneration. Cell. Mol. Life Sci. CMLS. 2020;77:4827&#x2013;4845. doi: 10.1007/s00018-020-03565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03565-0</ArticleId><ArticleId IdType="pmc">PMC7668291</ArticleId><ArticleId IdType="pubmed">32500266</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison A.F., Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem. J. 2017;474:1417&#x2013;1438. doi: 10.1042/BCJ20160499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160499</ArticleId><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014;15:509&#x2013;524. doi: 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kouwenhove M., Kedde M., Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat. Rev. Cancer. 2011;11:644&#x2013;656. doi: 10.1038/nrc3107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3107</ArticleId><ArticleId IdType="pubmed">21822212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju&#x17a;wik C.A., Drake S.S., Zhang Y., Paradis-Isler N., Sylvester A., Amar-Zifkin A., Douglas C., Morquette B., Moore C.S., Fournier A.E. microRNA dysregulation in neurodegenerative diseases: A systematic review. Prog. Neurobiol. 2019;182:101664. doi: 10.1016/j.pneurobio.2019.101664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.101664</ArticleId><ArticleId IdType="pubmed">31356849</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentze M.W., Castello A., Schwarzl T., Preiss T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 2018;19:327&#x2013;341. doi: 10.1038/nrm.2017.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.130</ArticleId><ArticleId IdType="pubmed">29339797</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Mu&#xf1;oz M.D., Turner M. Uncovering the role of RNA-binding proteins in gene expression in the immune system. Front. Immunol. 2018;9:1094. doi: 10.3389/fimmu.2018.01094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01094</ArticleId><ArticleId IdType="pmc">PMC5974052</ArticleId><ArticleId IdType="pubmed">29875770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunde B.M., Moore C., Varani G. RNA-binding proteins: Modular design for efficient function. Nat. Rev. Cell Biol. 2007;8:479&#x2013;490. doi: 10.1038/nrm2178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2178</ArticleId><ArticleId IdType="pmc">PMC5507177</ArticleId><ArticleId IdType="pubmed">17473849</ArticleId></ArticleIdList></Reference><Reference><Citation>Corley M., Burns M.C., Yeo G.W. How RNA-binding proteins interact with RNA: Molecules and mechanisms. Mol. Cell. 2020;78:9&#x2013;29. doi: 10.1016/j.molcel.2020.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.03.011</ArticleId><ArticleId IdType="pmc">PMC7202378</ArticleId><ArticleId IdType="pubmed">32243832</ArticleId></ArticleIdList></Reference><Reference><Citation>Re A., Joshi T., Kulberkyte E., Morris Q., Workman C.T. RNA-protein interactions: An overview. Methods Mol. Biol. 2014;1097:491&#x2013;521. doi: 10.1007/978-1-62703-709-9_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-709-9_23</ArticleId><ArticleId IdType="pubmed">24639174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee F.C.Y., Ule J. Advances in CLIP technologies for studies of protein-RNA interactions. Mol. Cell. 2018;69:354&#x2013;369. doi: 10.1016/j.molcel.2018.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.01.005</ArticleId><ArticleId IdType="pubmed">29395060</ArticleId></ArticleIdList></Reference><Reference><Citation>Nechay M., Kleiner R.E. High-throughput approaches to profile RNA-protein interactions. Curr. Opin. Chem. Biol. 2020;54:37&#x2013;44. doi: 10.1016/j.cbpa.2019.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2019.11.002</ArticleId><ArticleId IdType="pmc">PMC7131871</ArticleId><ArticleId IdType="pubmed">31812895</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Li B., Liang Q., Liu A., Qu L., Yang J. Classification and function of RNA-protein interactions. Wiley Interdiscip. Rev. 2020;11:e1601. doi: 10.1002/wrna.1601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1601</ArticleId><ArticleId IdType="pubmed">32488992</ArticleId></ArticleIdList></Reference><Reference><Citation>UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480&#x2013;D489. doi: 10.1093/nar/gkaa1100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1100</ArticleId><ArticleId IdType="pmc">PMC7778908</ArticleId><ArticleId IdType="pubmed">33237286</ArticleId></ArticleIdList></Reference><Reference><Citation>Berglund A.-C., Sj&#xf6;lund E., &#xd6;stlund G., Sonnhammer E.L.L. InParanoid 6: Eukaryotic ortholog clusters with inparalogs. Nucleic Acids Res. 2007;36:D263&#x2013;D266. doi: 10.1093/nar/gkm1020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm1020</ArticleId><ArticleId IdType="pmc">PMC2238924</ArticleId><ArticleId IdType="pubmed">18055500</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoit Bouvrette L.P., Bovaird S., Blanchette M., L&#xe9;cuyer E. oRNAment: A database of putative RNA binding protein target sites in the transcriptomes of model species. Nucleic Acids Res. 2020;48:D166&#x2013;D173. doi: 10.1093/nar/gkz986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz986</ArticleId><ArticleId IdType="pmc">PMC7145663</ArticleId><ArticleId IdType="pubmed">31724725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland L.C., Rintala-Maki N.D., White R.D., Morin C.D. RNA binding motif (RBM) proteins: A novel family of apoptosis modulators? J. Cell. Biochem. 2005;94:5&#x2013;24. doi: 10.1002/jcb.20204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.20204</ArticleId><ArticleId IdType="pubmed">15514923</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Nijhuis A., Keun H.C. RNA-binding motif protein 39 (RBM39): An emerging cancer target. Br. J. Pharmacol. 2020 doi: 10.1111/bph.15331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15331</ArticleId><ArticleId IdType="pubmed">33238031</ArticleId></ArticleIdList></Reference><Reference><Citation>She X., Lin Y., Liang R., Liu Z., Gao X., Ye J. RNA-binding motif protein 38 as a potential biomarker and therapeutic target in cancer. OncoTargets Ther. 2020;13:13225&#x2013;13236. doi: 10.2147/OTT.S278755.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S278755</ArticleId><ArticleId IdType="pmc">PMC7769143</ArticleId><ArticleId IdType="pubmed">33380811</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R.B., Lu X.L., Zhang C.Y., Yin D.C. RNA binding motif protein 3: A potential biomarker in cancer and therapeutic target in neuroprotection. Oncotarget. 2017;8:22235&#x2013;22250. doi: 10.18632/oncotarget.14755.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14755</ArticleId><ArticleId IdType="pmc">PMC5400660</ArticleId><ArticleId IdType="pubmed">28118608</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Astal H.I., Massad M., AlMatar M., Ekal H. Cellular functions of RNA-Binding Motif Protein 3 (RBM3): Clues in hypothermia, cancer biology and apoptosis. Protein Pept. Lett. 2016;23:828&#x2013;835. doi: 10.2174/0929866523666160628090340.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929866523666160628090340</ArticleId><ArticleId IdType="pubmed">27364162</ArticleId></ArticleIdList></Reference><Reference><Citation>Methawasin M., Strom J.G., Slater R.E., Fernandez V., Saripalli C., Granzier H. Experimentally increasing the compliance of titin through RNA Binding Motif-20 (RBM20) inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction. Circulation. 2016;134:1085&#x2013;1099. doi: 10.1161/CIRCULATIONAHA.116.023003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.023003</ArticleId><ArticleId IdType="pmc">PMC5069184</ArticleId><ArticleId IdType="pubmed">27630136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T., Ishida J., Shimizu Y., Kawakami H., Suda G., Muranaka T., Komatsu Y., Asaka M., Sakamoto N. Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer. Tumor Biol. 2017;39:1010428317694547. doi: 10.1177/1010428317694547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1010428317694547</ArticleId><ArticleId IdType="pubmed">28347247</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson T.C., Du L., Janesko-Feldman K., Vagni V.A., Dezfulian C., Poloyac S.M., Jackson E.K., Clark R.S., Kochanek P.M. The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice. Br. J. Pharmacol. 2015;35:655&#x2013;666. doi: 10.1038/jcbfm.2014.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.242</ArticleId><ArticleId IdType="pmc">PMC4420885</ArticleId><ArticleId IdType="pubmed">25586139</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuens T., Bouhy D., Timmerman V. The hnRNP family: Insights into their role in health and disease. Hum. Genet. 2016;135:851&#x2013;867. doi: 10.1007/s00439-016-1683-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1683-5</ArticleId><ArticleId IdType="pmc">PMC4947485</ArticleId><ArticleId IdType="pubmed">27215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S.P., Tang Y.H., Smith R. Functional diversity of the hnRNPs: Past, present and perspectives. Biochem. J. 2010;430:379&#x2013;392. doi: 10.1042/BJ20100396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20100396</ArticleId><ArticleId IdType="pubmed">20795951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou S.H., Wu F., Harrich D., Garc&#xed;a-Mart&#xed;nez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 1995;69:3584&#x2013;3596. doi: 10.1128/JVI.69.6.3584-3596.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton C.F., Cenik B., Cenik B.K., Herz J., Yu G. TDP-43 in central nervous system development and function: Clues to TDP-43-associated neurodegeneration. Biol. Chem. 2012;393:589&#x2013;594. doi: 10.1515/hsz-2012-0115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hsz-2012-0115</ArticleId><ArticleId IdType="pmc">PMC3537500</ArticleId><ArticleId IdType="pubmed">22944662</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 2001;276:36337&#x2013;36343. doi: 10.1074/jbc.M104236200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose J.K., Wang I.F., Hung L., Tarn W.Y., Shen C.K. TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J. Biol. Chem. 2008;283:28852&#x2013;28859. doi: 10.1074/jbc.M805376200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M805376200</ArticleId><ArticleId IdType="pmc">PMC2661999</ArticleId><ArticleId IdType="pubmed">18703504</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K., Leystra-Lantz C., Yang W., Jaffee H., Strong M.J. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) Brain Res. 2009;1305:168&#x2013;182. doi: 10.1016/j.brainres.2009.09.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.105</ArticleId><ArticleId IdType="pubmed">19815002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M.L., Perry G., Wang X. Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem. 2018 doi: 10.1111/jnc.14327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Svetoni F., Frisone P., Paronetto M.P. Role of FET proteins in neurodegenerative disorders. RNA Biol. 2016;13:1089&#x2013;1102. doi: 10.1080/15476286.2016.1211225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1211225</ArticleId><ArticleId IdType="pmc">PMC5100351</ArticleId><ArticleId IdType="pubmed">27415968</ArticleId></ArticleIdList></Reference><Reference><Citation>Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., De Jong P., Rouleau G., et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162&#x2013;165. doi: 10.1038/359162a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/359162a0</ArticleId><ArticleId IdType="pubmed">1522903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolotti A., Lutz Y., Heard D.J., Chambon P., Tora L. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 1996;15:5022&#x2013;5031. doi: 10.1002/j.1460-2075.1996.tb00882.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1996.tb00882.x</ArticleId><ArticleId IdType="pmc">PMC452240</ArticleId><ArticleId IdType="pubmed">8890175</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan A.Y., Manley J.L. The TET family of proteins: Functions and roles in disease. J. Mol. Cell Biol. 2009;1:82&#x2013;92. doi: 10.1093/jmcb/mjp025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjp025</ArticleId><ArticleId IdType="pmc">PMC2905059</ArticleId><ArticleId IdType="pubmed">19783543</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Cech T.R., Parker R.R. Biochemical Properties and Biological Functions of FET Proteins. Annu. Rev. Biochem. 2015;84:355&#x2013;379. doi: 10.1146/annurev-biochem-060614-034325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060614-034325</ArticleId><ArticleId IdType="pubmed">25494299</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinman M.N., Lou H. Diverse molecular functions of Hu proteins. Cell. Mol. Life Sci. CMLS. 2008;65:3168&#x2013;3181. doi: 10.1007/s00018-008-8252-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-008-8252-6</ArticleId><ArticleId IdType="pmc">PMC2580827</ArticleId><ArticleId IdType="pubmed">18581050</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirisis A.A., Carew T.J. The ELAV family of RNA-binding proteins in synaptic plasticity and long-term memory. Neurobiol. Learn. Mem. 2019;161:143&#x2013;148. doi: 10.1016/j.nlm.2019.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2019.04.007</ArticleId><ArticleId IdType="pmc">PMC6529270</ArticleId><ArticleId IdType="pubmed">30998973</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta T., Ladd A.N. The importance of CELF control: Molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins. Wiley Interdiscip. Rev. RNA. 2012;3:104&#x2013;121. doi: 10.1002/wrna.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.107</ArticleId><ArticleId IdType="pmc">PMC3243963</ArticleId><ArticleId IdType="pubmed">22180311</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo J.M., Spickett C. The role of CELF proteins in neurological disorders. RNA Biol. 2010;7:474&#x2013;479. doi: 10.4161/rna.7.4.12345.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.7.4.12345</ArticleId><ArticleId IdType="pmc">PMC3062235</ArticleId><ArticleId IdType="pubmed">20622515</ArticleId></ArticleIdList></Reference><Reference><Citation>Good P.J., Chen Q., Warner S.J., Herring D.C. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J. Biol. Chem. 2000;275:28583&#x2013;28592. doi: 10.1074/jbc.M003083200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M003083200</ArticleId><ArticleId IdType="pubmed">10893231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd A.N. CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease. Mol. Cell. Neurosci. 2013;56:456&#x2013;464. doi: 10.1016/j.mcn.2012.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2012.12.003</ArticleId><ArticleId IdType="pmc">PMC3650117</ArticleId><ArticleId IdType="pubmed">23247071</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes J.J., Pritchard M.A., Planas A.M., Bosch A., Ferrer I., Estivill X. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum. Mol. Genet. 1995;4:1935&#x2013;1944. doi: 10.1093/hmg/4.10.1935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/4.10.1935</ArticleId><ArticleId IdType="pubmed">8595418</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.K., Ahnn J. Regulator of Calcineurin (RCAN): Beyond down syndrome critical region. Mol. Cells. 2020;43:671&#x2013;685. doi: 10.14348/molcells.2020.0060.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2020.0060</ArticleId><ArticleId IdType="pmc">PMC7468584</ArticleId><ArticleId IdType="pubmed">32576715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S., Li H., Hogan P.G., Cunningham K.W. Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast. Mol. Cell. Biol. 2009;29:2777&#x2013;2793. doi: 10.1128/MCB.01197-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01197-08</ArticleId><ArticleId IdType="pmc">PMC2682025</ArticleId><ArticleId IdType="pubmed">19273587</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Sheftic S.R., Grigoriu S., Schwieters C.D., Page R., Peti W. The structure of the RCAN1:CN complex explains the inhibition of and substrate recruitment by calcineurin. Sci. Adv. 2020;6:eaba3681. doi: 10.1126/sciadv.aba3681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aba3681</ArticleId><ArticleId IdType="pmc">PMC7458460</ArticleId><ArticleId IdType="pubmed">32936779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingsbury T.J., Cunningham K.W. A conserved family of calcineurin regulators. Genes Dev. 2000;14:1595&#x2013;1604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC316734</ArticleId><ArticleId IdType="pubmed">10887154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M., Okano H., Blendy J.A., Montell C. Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development. Neuron. 1994;13:67&#x2013;81. doi: 10.1016/0896-6273(94)90460-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(94)90460-X</ArticleId><ArticleId IdType="pubmed">8043282</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano H., Kawahara H., Toriya M., Nakao K., Shibata S., Imai T. Function of RNA-binding protein Musashi-1 in stem cells. Exp. Cell Res. 2005;306:349&#x2013;356. doi: 10.1016/j.yexcr.2005.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2005.02.021</ArticleId><ArticleId IdType="pubmed">15925591</ArticleId></ArticleIdList></Reference><Reference><Citation>De Andr&#xe9;s-Aguayo L., Varas F., Graf T. Musashi 2 in hematopoiesis. Curr. Opin. Hematol. 2012;19:268&#x2013;272. doi: 10.1097/MOH.0b013e328353c778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0b013e328353c778</ArticleId><ArticleId IdType="pubmed">22517588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakibara S.-I., Nakamura Y., Satoh H., Okano H. RNA-Binding Protein Musashi2: Developmentally Regulated Expression in Neural Precursor Cells and Subpopulations of Neurons in Mammalian CNS. J. Neurosci. 2001;21:8091&#x2013;8107. doi: 10.1523/JNEUROSCI.21-20-08091.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-20-08091.2001</ArticleId><ArticleId IdType="pmc">PMC6763847</ArticleId><ArticleId IdType="pubmed">11588182</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox R.G., Park F.D., Koechlein C.S., Kritzik M., Reya T. Musashi signaling in stem cells and cancer. Annu. Rev. Cell Dev. Biol. 2015;31:249&#x2013;267. doi: 10.1146/annurev-cellbio-100814-125446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100814-125446</ArticleId><ArticleId IdType="pubmed">26566113</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakibara S.-I., Nakamura Y., Yoshida T., Shibata S., Koike M., Takano H., Ueda S., Uchiyama Y., Noda T., Okano H. RNA-binding protein Musashi family: Roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc. Natl. Acad. Sci. USA. 2002;99:15194&#x2013;15199. doi: 10.1073/pnas.232087499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.232087499</ArticleId><ArticleId IdType="pmc">PMC137566</ArticleId><ArticleId IdType="pubmed">12407178</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudinov A.E., Karanicolas J., Golemis E.A., Boumber Y. Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets. Clin. Cancer Res. 2017;23:2143&#x2013;2153. doi: 10.1158/1078-0432.CCR-16-2728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-16-2728</ArticleId><ArticleId IdType="pmc">PMC5413399</ArticleId><ArticleId IdType="pubmed">28143872</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagerman R.J., Berry-Kravis E., Hazlett H.C., Bailey D.B., Jr., Moine H., Kooy R.F., Tassone F., Gantois I., Sonenberg N., Mandel J.L., et al. Fragile X syndrome. Nat. Rev. Dis. Primers. 2017;3:17065. doi: 10.1038/nrdp.2017.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.65</ArticleId><ArticleId IdType="pubmed">28960184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai A., Valdez-Sinon A.N., Bassell G.J. Regulation of RNA granules by FMRP and implications for neurological diseases. Traffic. 2020;21:454&#x2013;462. doi: 10.1111/tra.12733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12733</ArticleId><ArticleId IdType="pmc">PMC7377269</ArticleId><ArticleId IdType="pubmed">32374065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascano M., Jr., Mukherjee N., Bandaru P., Miller J.B., Nusbaum J.D., Corcoran D.L., Langlois C., Munschauer M., Dewell S., Hafner M., et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492:382&#x2013;386. doi: 10.1038/nature11737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11737</ArticleId><ArticleId IdType="pmc">PMC3528815</ArticleId><ArticleId IdType="pubmed">23235829</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder M., Johnson R.H., Palanisamy V. Fragile X-related protein family: A double-edged sword in neurodevelopmental disorders and cancer. Critical Rev. Biochem. Mol. Biol. 2020;55:409&#x2013;424. doi: 10.1080/10409238.2020.1810621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2020.1810621</ArticleId><ArticleId IdType="pmc">PMC7695039</ArticleId><ArticleId IdType="pubmed">32878499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogeveen A.T., Willemsen R., Oostra B.A. Fragile X syndrome, the Fragile X related proteins, and animal models. Microsc. Res. Tech. 2002;57:148&#x2013;155. doi: 10.1002/jemt.10064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.10064</ArticleId><ArticleId IdType="pubmed">12112450</ArticleId></ArticleIdList></Reference><Reference><Citation>Patzlaff N.E., Shen M., Zhao X. Regulation of adult neurogenesis by the fragile x family of rna binding proteins. Brain Plast. 2018;3:205&#x2013;223. doi: 10.3233/BPL-170061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BPL-170061</ArticleId><ArticleId IdType="pmc">PMC6091053</ArticleId><ArticleId IdType="pubmed">30151344</ArticleId></ArticleIdList></Reference><Reference><Citation>Waris S., Wilce M.C., Wilce J.A. RNA recognition and stress granule formation by TIA proteins. Int. J. Mol. Sci. 2014;15:23377&#x2013;23388. doi: 10.3390/ijms151223377.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms151223377</ArticleId><ArticleId IdType="pmc">PMC4284772</ArticleId><ArticleId IdType="pubmed">25522169</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer C., Garzia A., Mazzola M., Gerstberger S., Molina H., Tuschl T. The TIA1 RNA-binding protein family regulates EIF2AK2-mediated stress response and cell cycle progression. Mol. Cell. 2018;69:622&#x2013;635. doi: 10.1016/j.molcel.2018.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.01.011</ArticleId><ArticleId IdType="pmc">PMC5816707</ArticleId><ArticleId IdType="pubmed">29429924</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck A.R., Medley Q.G., O&#x2019;Brien S., Anderson P., Streuli M. Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. Nucleic Acids Res. 1996;24:3829&#x2013;3835. doi: 10.1093/nar/24.19.3829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/24.19.3829</ArticleId><ArticleId IdType="pmc">PMC146163</ArticleId><ArticleId IdType="pubmed">8871565</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini Y., Chen J., Patial S. The tristetraprolin family of RNA-binding proteins in cancer: Progress and future prospects. Cancers. 2020;12:1539. doi: 10.3390/cancers12061539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12061539</ArticleId><ArticleId IdType="pmc">PMC7352335</ArticleId><ArticleId IdType="pubmed">32545247</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappl P., Br&#xfc;ne B., Schmid T. Role of tristetraprolin in the resolution of inflammation. Biology. 2021;10:66. doi: 10.3390/biology10010066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10010066</ArticleId><ArticleId IdType="pmc">PMC7832405</ArticleId><ArticleId IdType="pubmed">33477783</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.M., Lee T.H., Kang T.H. Roles of tristetraprolin in tumorigenesis. Int. J. Mol. Sci. 2018;19:3384. doi: 10.3390/ijms19113384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19113384</ArticleId><ArticleId IdType="pmc">PMC6274954</ArticleId><ArticleId IdType="pubmed">30380668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Peng Q., Wang L., Zhang X., Huang L., Wang J., Qin Z. Serine/arginine-rich splicing factors: The bridge linking alternative splicing and cancer. Int. J. Biol. Sci. 2020;16:2442&#x2013;2453. doi: 10.7150/ijbs.46751.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.46751</ArticleId><ArticleId IdType="pmc">PMC7378643</ArticleId><ArticleId IdType="pubmed">32760211</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch A., Hertel K.J. Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip. Rev. RNA. 2012;3:1&#x2013;12. doi: 10.1002/wrna.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.100</ArticleId><ArticleId IdType="pmc">PMC3235224</ArticleId><ArticleId IdType="pubmed">21898828</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahebi M., Hanafi M.M., Van Wijnen A.J., Azizi P., Abiri R., Ashkani S., Taheri S. Towards understanding pre-mRNA splicing mechanisms and the role of SR proteins. Gene. 2016;587:107&#x2013;119. doi: 10.1016/j.gene.2016.04.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2016.04.057</ArticleId><ArticleId IdType="pubmed">27154819</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckanovich R.J., Posner J.B., Darnell R.B. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron. 1993;11:657&#x2013;672. doi: 10.1016/0896-6273(93)90077-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(93)90077-5</ArticleId><ArticleId IdType="pubmed">8398153</ArticleId></ArticleIdList></Reference><Reference><Citation>Meldolesi J. Alternative splicing by NOVA factors: From gene expression to cell physiology and pathology. Int. J. Mol. Sci. 2020;21:3941. doi: 10.3390/ijms21113941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21113941</ArticleId><ArticleId IdType="pmc">PMC7312376</ArticleId><ArticleId IdType="pubmed">32486302</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckanovich R.J., Darnell R.B. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 1997;17:3194&#x2013;3201. doi: 10.1128/MCB.17.6.3194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.17.6.3194</ArticleId><ArticleId IdType="pmc">PMC232172</ArticleId><ArticleId IdType="pubmed">9154818</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho M.B., Attig J., Bellora N., K&#xf6;nig J., Hallegger M., Kayikci M., Eyras E., Ule J., Smith C.W. Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. EMBO J. 2015;34:653&#x2013;668. doi: 10.15252/embj.201489852.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201489852</ArticleId><ArticleId IdType="pmc">PMC4365034</ArticleId><ArticleId IdType="pubmed">25599992</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho M.B., Attig J., Ule J., Smith C.W. Matrin3: Connecting gene expression with the nuclear matrix. Wiley Interdiscip. Rev. RNA. 2016;7:303&#x2013;315. doi: 10.1002/wrna.1336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1336</ArticleId><ArticleId IdType="pubmed">26813864</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura Y., Oshima T., Yamamoto M., Reyes C.J., Costa Cruz P.H., Shibuya T., Kawahara Y. Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cells. 2017;22:785&#x2013;798. doi: 10.1111/gtc.12512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12512</ArticleId><ArticleId IdType="pubmed">28695676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayasu H., Berezney R. Nuclear matrins: Identification of the major nuclear matrix proteins. Proc. Natl. Acad. Sci. USA. 1991;88:10312&#x2013;10316. doi: 10.1073/pnas.88.22.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.22.10312</ArticleId><ArticleId IdType="pmc">PMC52918</ArticleId><ArticleId IdType="pubmed">1946450</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Shewmaker F., Pandey U.B. Stress granules at the intersection of autophagy and ALS. Brain Res. 2016;1649:189&#x2013;200. doi: 10.1016/j.brainres.2016.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.05.022</ArticleId><ArticleId IdType="pmc">PMC5055418</ArticleId><ArticleId IdType="pubmed">27181519</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Pioro E.P., Boehringer A., Chia R., Feit H., Renton A.E., Pliner H.A., Abramzon Y., Marangi G., Winborn B.J., et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 2014;17:664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Blobel G. A protein of molecular weight 78,000 bound to the polyadenylate region of eukaryotic messenger RNAs. Proc. Natl. Acad. Sci. USA. 1973;70:924&#x2013;928. doi: 10.1073/pnas.70.3.924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.70.3.924</ArticleId><ArticleId IdType="pmc">PMC433389</ArticleId><ArticleId IdType="pubmed">4515002</ArticleId></ArticleIdList></Reference><Reference><Citation>Derry M.C., Yanagiya A., Martineau Y., Sonenberg N. Regulation of poly(A)-binding protein through PABP-interacting proteins. Cold Spring Harb. Symp. Quant. Biol. 2006;71:537&#x2013;543. doi: 10.1101/sqb.2006.71.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2006.71.061</ArticleId><ArticleId IdType="pubmed">17381337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangus D.A., Evans M.C., Jacobson A. Poly(A)-binding proteins: Multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol. 2003;4:223. doi: 10.1186/gb-2003-4-7-223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2003-4-7-223</ArticleId><ArticleId IdType="pmc">PMC193625</ArticleId><ArticleId IdType="pubmed">12844354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge H., Zhou D., Tong S., Gao Y., Teng M., Niu L. Crystal structure and possible dimerization of the single RRM of human PABPN1. Proteins. 2008;71:1539&#x2013;1545. doi: 10.1002/prot.21973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.21973</ArticleId><ArticleId IdType="pubmed">18275081</ArticleId></ArticleIdList></Reference><Reference><Citation>Brais B., Bouchard J.P., Xie Y.G., Rochefort D.L., Chr&#xe9;tien N., Tom&#xe9; F.M., Lafreni&#xe8;re R.G., Rommens J.M., Uyama E., Nohira O., et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 1998;18:164&#x2013;167. doi: 10.1038/ng0298-164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0298-164</ArticleId><ArticleId IdType="pubmed">9462747</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman M., Rivers C., Lee Y.B., Idris J., Uney J. The increasing diversity of functions attributed to the SAFB family of RNA-/DNA-binding proteins. Biochem. J. 2016;473:4271&#x2013;4288. doi: 10.1042/BCJ20160649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160649</ArticleId><ArticleId IdType="pubmed">27888239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Rio D.C. Mechanisms and regulation of alternative pre-mRNA splicing. Annu. Rev. Biochem. 2015;84:291&#x2013;323. doi: 10.1146/annurev-biochem-060614-034316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060614-034316</ArticleId><ArticleId IdType="pmc">PMC4526142</ArticleId><ArticleId IdType="pubmed">25784052</ArticleId></ArticleIdList></Reference><Reference><Citation>So B.R., Zhang Z., Dreyfuss G. Chapter 6&#x2014;The function of survival motor neuron complex and its role in spinal muscular atrophy pathogenesis. In: Sumner C.J., Paushkin S., Ko C.-P., editors. Spinal Muscular Atrophy. Academic Press; Cambridge, MA, USA: 2017. pp. 99&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-803685-3.00006-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Urlaub H., Raker V.A., Kostka S., L&#xfc;hrmann R. Sm protein-Sm site RNA interactions within the inner ring of the spliceosomal snRNP core structure. EMBO J. 2001;20:187&#x2013;196. doi: 10.1093/emboj/20.1.187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.1.187</ArticleId><ArticleId IdType="pmc">PMC140196</ArticleId><ArticleId IdType="pubmed">11226169</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Cruz J., Karbstein K., Woolford J.L.J. Functions of ribosomal proteins in assembly of eukaryotic ribosomes in vivo. Annu. Rev. Biochem. 2015;84:93&#x2013;129. doi: 10.1146/annurev-biochem-060614-033917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060614-033917</ArticleId><ArticleId IdType="pmc">PMC4772166</ArticleId><ArticleId IdType="pubmed">25706898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Liao W.J., Liao J.M., Liao P., Lu H. Ribosomal proteins: Functions beyond the ribosome. J. Mol. Cell Biol. 2015;7:92&#x2013;104. doi: 10.1093/jmcb/mjv014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjv014</ArticleId><ArticleId IdType="pmc">PMC4481666</ArticleId><ArticleId IdType="pubmed">25735597</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatter H., Myasnikov A.G., Natchiar S.K., Klaholz B.P. Structure of the human 80S ribosome. Nature. 2015;520:640&#x2013;645. doi: 10.1038/nature14427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14427</ArticleId><ArticleId IdType="pubmed">25901680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ban N., Beckmann R., Cate J.H., Dinman J.D., Dragon F., Ellis S.R., Lafontaine D.L., Lindahl L., Liljas A., Lipton J.M., et al. A new system for naming ribosomal proteins. Curr. Opin. Struct. Biol. 2014;24:165&#x2013;169. doi: 10.1016/j.sbi.2014.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2014.01.002</ArticleId><ArticleId IdType="pmc">PMC4358319</ArticleId><ArticleId IdType="pubmed">24524803</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffreda A., Rigamonti A., Barabino S.M., Lenzken S.C. RNA-binding proteins in the regulation of miRNA activity: A focus on neuronal functions. Biomolecules. 2015;5:2363&#x2013;2387. doi: 10.3390/biom5042363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom5042363</ArticleId><ArticleId IdType="pmc">PMC4693239</ArticleId><ArticleId IdType="pubmed">26437437</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroynowska-Czerwinska A., Fiszer A., Krzyzosiak W.J. The panorama of miRNA-mediated mechanisms in mammalian cells. Cell. Mol. Life Sci. CMLS. 2014;71:2253&#x2013;2270. doi: 10.1007/s00018-013-1551-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1551-6</ArticleId><ArticleId IdType="pmc">PMC4031385</ArticleId><ArticleId IdType="pubmed">24468964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. USA. 2012;109:3347&#x2013;3352. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M., Dini Modigliani S., Torrelli G., Rosa A., Di Carlo V., Caffarelli E., Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012;31:4502&#x2013;4510. doi: 10.1038/emboj.2012.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.319</ArticleId><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.Y., Hwang Y.J., Jung M.K., Choe J., Kim Y., Kim S., Lee C.J., Ahn H., Lee J., Kowall N.W., et al. A multifunctional protein EWS regulates the expression of Drosha and microRNAs. Cell Death Differ. 2014;21:136&#x2013;145. doi: 10.1038/cdd.2013.144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.144</ArticleId><ArticleId IdType="pmc">PMC3857629</ArticleId><ArticleId IdType="pubmed">24185621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang H., Zhang K., Fox-Walsh K., Yang Y., Zhang C., Huang J., Li H., Zhou Y., Fu X.D. The RNA binding protein EWS is broadly involved in the regulation of pri-miRNA processing in mammalian cells. Nucleic Acids Res. 2017;45:12481&#x2013;12495. doi: 10.1093/nar/gkx912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx912</ArticleId><ArticleId IdType="pmc">PMC5716145</ArticleId><ArticleId IdType="pubmed">30053258</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury N.R., De Lima Alves F., De Andr&#xe9;s-Aguayo L., Graf T., C&#xe1;ceres J.F., Rappsilber J., Michlewski G. Tissue-specific control of brain-enriched miR-7 biogenesis. Genes Dev. 2013;27:24&#x2013;38. doi: 10.1101/gad.199190.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.199190.112</ArticleId><ArticleId IdType="pmc">PMC3553281</ArticleId><ArticleId IdType="pubmed">23307866</ArticleId></ArticleIdList></Reference><Reference><Citation>Michlewski G., C&#xe1;ceres J.F. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat. Struct. Mol. Biol. 2010;17:1011&#x2013;1018. doi: 10.1038/nsmb.1874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1874</ArticleId><ArticleId IdType="pmc">PMC2923024</ArticleId><ArticleId IdType="pubmed">20639884</ArticleId></ArticleIdList></Reference><Reference><Citation>Guil S., C&#xe1;ceres J.F. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat. Struct. Mol. Biol. 2007;14:591&#x2013;596. doi: 10.1038/nsmb1250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1250</ArticleId><ArticleId IdType="pubmed">17558416</ArticleId></ArticleIdList></Reference><Reference><Citation>Towbin H., Wenter P., Guennewig B., Imig J., Zagalak J.A., Gerber A.P., Hall J. Systematic screens of proteins binding to synthetic microRNA precursors. Nucleic Acids Res. 2013;41:e47. doi: 10.1093/nar/gks1197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1197</ArticleId><ArticleId IdType="pmc">PMC3561989</ArticleId><ArticleId IdType="pubmed">23221640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooshapur H., Choudhury N.R., Simon B., M&#xfc;hlbauer M., Jussupow A., Fernandez N., Jones A.N., Dallmann A., Gabel F., Camilloni C., et al. Structural basis for terminal loop recognition and stimulation of pri-miRNA-18a processing by hnRNP A1. Nat. Commun. 2018;9:2479. doi: 10.1038/s41467-018-04871-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04871-9</ArticleId><ArticleId IdType="pmc">PMC6018666</ArticleId><ArticleId IdType="pubmed">29946118</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmohsen K., Tominaga-Yamanaka K., Srikantan S., Yoon J.H., Kang M.J., Gorospe M. RNA-binding protein AUF1 represses Dicer expression. Nucleic Acids Res. 2012;40:11531&#x2013;11544. doi: 10.1093/nar/gks930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks930</ArticleId><ArticleId IdType="pmc">PMC3526313</ArticleId><ArticleId IdType="pubmed">23066106</ArticleId></ArticleIdList></Reference><Reference><Citation>King I.N., Yartseva V., Salas D., Kumar A., Heidersbach A., Ando D.M., Stallings N.R., Elliott J.L., Srivastava D., Ivey K.N. The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex. J. Biol. Chem. 2014;289:14263&#x2013;14271. doi: 10.1074/jbc.M114.561902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.561902</ArticleId><ArticleId IdType="pmc">PMC4022891</ArticleId><ArticleId IdType="pubmed">24719334</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti F., Kaiser C., Zdanowicz-Specht A., Hentze M.W. PABP and the poly(A) tail augment microRNA repression by facilitated miRISC binding. Nat. Struct. Mol. Biol. 2012;19:603&#x2013;608. doi: 10.1038/nsmb.2309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2309</ArticleId><ArticleId IdType="pubmed">22635249</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanowska J., Joshi A. From Genotype to Phenotype: Through Chromatin. Genes. 2019;10:76. doi: 10.3390/genes10020076.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes10020076</ArticleId><ArticleId IdType="pmc">PMC6410296</ArticleId><ArticleId IdType="pubmed">30678090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsui J., Tsuji S. Genomic aspects of sporadic neurodegenerative diseases. Biochem Biophys. Res. Commun. 2014;452:221&#x2013;225. doi: 10.1016/j.bbrc.2014.07.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.07.098</ArticleId><ArticleId IdType="pubmed">25078619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Mackenzie I.R.A. Review: Neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol. Appl. Neurobiol. 2019;45:19&#x2013;40. doi: 10.1111/nan.12526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12526</ArticleId><ArticleId IdType="pubmed">30357887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D.M.A., Snowden J.S. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype. Brain Pathol. 2017;27:723&#x2013;736. doi: 10.1111/bpa.12486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12486</ArticleId><ArticleId IdType="pmc">PMC8029341</ArticleId><ArticleId IdType="pubmed">28100023</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel B.L., Clark M.C., Geschwind D.H. The neurogenetics of atypical parkinsonian disorders. Semin. Neurol. 2014;34:217&#x2013;224. doi: 10.1055/s-0034-1381738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1381738</ArticleId><ArticleId IdType="pmc">PMC4305275</ArticleId><ArticleId IdType="pubmed">24963681</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J.R., Gleixner A.M., Mauna J.C., Gomes E., DeChellis-Marks M.R., Needham P.G., Copley K.E., Hurtle B., Portz B., Pyles N.J., et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102:321&#x2013;338. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J.P., Pletnikova O., Troncoso J.C., Wong P.C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Zhan L., Hanson K.A., Tibbetts R.S. High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity. Hum. Mol. Genet. 2012;21:4845&#x2013;4856. doi: 10.1093/hmg/dds321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds321</ArticleId><ArticleId IdType="pmc">PMC3529575</ArticleId><ArticleId IdType="pubmed">22872699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley Z.C.E., Campos-Melo D., Strong M.J. Evidence of A negative feedback network between TDP-43 and miRNAs dependent on TDP-43 nuclear localization. J. Mol. Biol. 2020;432:166695. doi: 10.1016/j.jmb.2020.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.10.029</ArticleId><ArticleId IdType="pubmed">33137311</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in amyotrophic lateral sclerosis: A role in the regulation of NFL mRNA levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z., Chen X., Chen R. Transcriptome-wide analysis of TDP-43 binding small RNAs identifies miR-NID1 (miR-8485), a novel miRNA that represses NRXN1 expression. Genomics. 2014;103:76&#x2013;82. doi: 10.1016/j.ygeno.2013.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2013.06.006</ArticleId><ArticleId IdType="pubmed">23827811</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Drexler H.C.A., Wang J., Tripathi P., Distler T., Heisterkamp P., Anderson E.N., Kour S., Moraiti A., Maharana S., et al. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138:67&#x2013;84. doi: 10.1007/s00401-019-01998-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01998-x</ArticleId><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Pratt G.A., Vu A.Q., Hutt K.R., Martinez F.J., Sundararaman B., Batra R., Freese P., Lambert N.J., Huelga S.C., et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016;7:12143. doi: 10.1038/ncomms12143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12143</ArticleId><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Woldemichael B.T., Kremer E.A., Laferriere F., Gaur N., Afroz T., Polymenidou M., Mansuy I.M. Memory decline and its reversal in aging and neurodegeneration involve miR-183/96/182 biogenesis. Mol. Neurobiol. 2019;56:3451&#x2013;3462. doi: 10.1007/s12035-018-1314-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1314-3</ArticleId><ArticleId IdType="pubmed">30128653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim F., Maragkakis M., Alexiou P., Maronski M.A., Dichter M.A., Mourelatos Z. Identification of in vivo, conserved, TAF15 RNA binding sites reveals the impact of TAF15 on the neuronal transcriptome. Cell Rep. 2013;3:301&#x2013;308. doi: 10.1016/j.celrep.2013.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.01.021</ArticleId><ArticleId IdType="pmc">PMC3594071</ArticleId><ArticleId IdType="pubmed">23416048</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Zou S., Weijdeg&#xe5;rd B., Chen J., Cong Q., Fernandez-Rodriguez J., Wang L., Billig H., Shao R. The onset of human ectopic pregnancy demonstrates a differential expression of miRNAs and their cognate targets in the Fallopian tube. Int. J. Clin. Exp. Pathol. 2014;7:64&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3885461</ArticleId><ArticleId IdType="pubmed">24427327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballarino M., Jobert L., Demb&#xe9;l&#xe9; D., de la Grange P., Auboeuf D., Tora L. TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs. Oncogene. 2013;32:4646&#x2013;4655. doi: 10.1038/onc.2012.490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2012.490</ArticleId><ArticleId IdType="pubmed">23128393</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung Y.T., Peng K.C., Chen Y.C., Yen Y.P., Chang M., Thams S., Chen J.A. Mir-17&#x223c;92 Confers motor neuron subtype differential resistance to ALS-associated degeneration. Cell Stem Cell. 2019;25:193&#x2013;209. doi: 10.1016/j.stem.2019.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.04.016</ArticleId><ArticleId IdType="pubmed">31155482</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischbein M., Baron D.M., Lin Y.C., Gall K.V., Landers J.E., Fallini C., Bosco D.A. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing. J. Biol. Chem. 2019;294:10194&#x2013;10210. doi: 10.1074/jbc.RA118.005933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005933</ArticleId><ArticleId IdType="pmc">PMC6664169</ArticleId><ArticleId IdType="pubmed">31092554</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa C., Fenoglio C., De Riz M., Clerici F., Marcone A., Benussi L., Ghidoni R., Gallone S., Cortini F., Serpente M., et al. Role of hnRNP-A1 and miR-590-3p in neuronal death: Genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. Rejuvenation Res. 2011;14:275&#x2013;281. doi: 10.1089/rej.2010.1123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/rej.2010.1123</ArticleId><ArticleId IdType="pubmed">21548758</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Fagegaltier D., Agius P., Davis-Porada J., Gregory J., Hubbard I., Kang K., Kim D., Phatnani H., Shneider N.A., et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. eLife. 2018;7 doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Li L., Zhang X., Zhao H., Wei M., Zhai W., Wang B., Yan Y. LncRNA RP11-670E13.6, interacted with hnRNPH, delays cellular senescence by sponging microRNA-663a in UVB damaged dermal fibroblasts. Aging. 2019;11:5992&#x2013;6013. doi: 10.18632/aging.102159.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102159</ArticleId><ArticleId IdType="pmc">PMC6738423</ArticleId><ArticleId IdType="pubmed">31444317</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrabec K., Bo&#x161;tjan&#x10d;i&#x10d; E., Koritnik B., Leonardis L., Dolenc Gro&#x161;elj L., Zidar J., Rogelj B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients. Front. Mol. Neurosci. 2018;11:106. doi: 10.3389/fnmol.2018.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5893848</ArticleId><ArticleId IdType="pubmed">29670510</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasperini L., Rossi A., Cornella N., Peroni D., Zuccotti P., Potrich V., Quattrone A., Macchi P. The hnRNP RALY regulates PRMT1 expression and interacts with the ALS-linked protein FUS: Implication for reciprocal cellular localization. Mol. Biol. Cell. 2018;29:3067&#x2013;3081. doi: 10.1091/mbc.E18-02-0108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E18-02-0108</ArticleId><ArticleId IdType="pmc">PMC6340211</ArticleId><ArticleId IdType="pubmed">30354839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Wan A., Zhou Z., Chen D., Liang H., Liu C., Yan S., Niu Y., Lin Z., Zhan S., et al. RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer. Gut. 2020 doi: 10.1136/gutjnl-2020-320652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-320652</ArticleId><ArticleId IdType="pubmed">33219048</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q., Yalamanchili H.K., Park J., De Maio A., Lu H.C., Wan Y.W., White J.J., Bondar V.V., Sayegh L.S., Liu X., et al. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum. Mol. Genet. 2016;25:5083&#x2013;5093. doi: 10.1093/hmg/ddw337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw337</ArticleId><ArticleId IdType="pmc">PMC5968355</ArticleId><ArticleId IdType="pubmed">28007900</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong J., Huang M., Wang F., Ma X., Liu H., Tu Y., Xing L., Zhu X., Zheng H., Fang J., et al. RBM45 competes with HDAC1 for binding to FUS in response to DNA damage. Nucleic Acids Res. 2017;45:12862&#x2013;12876. doi: 10.1093/nar/gkx1102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1102</ArticleId><ArticleId IdType="pmc">PMC5728411</ArticleId><ArticleId IdType="pubmed">29140459</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin G., Chen R., Zhang X. Identification of key microRNAs, transcription factors and genes associated with congenital obstructive nephropathy in a mouse model of megabladder. Gene. 2018;650:77&#x2013;85. doi: 10.1016/j.gene.2018.01.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.01.063</ArticleId><ArticleId IdType="pubmed">29410288</ArticleId></ArticleIdList></Reference><Reference><Citation>Pronto-Laborinho A.C., Pinto S., de Carvalho M. Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis. BioMed Res. Int. 2014;2014:947513. doi: 10.1155/2014/947513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/947513</ArticleId><ArticleId IdType="pmc">PMC4022172</ArticleId><ArticleId IdType="pubmed">24987705</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P.R., Kazoka M., Wollff H., Shaw P.J., Kirby J. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front. Neurosci. 2017;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Orco M., Sardone V., Gardiner A.S., Pansarasa O., Bordoni M., Perrone-Bizzozero N.I., Cereda C. HuD regulates SOD1 expression during oxidative stress in differentiated neuroblastoma cells and sporadic ALS motor cortex. Neurobiol. Dis. 2021;148:105211. doi: 10.1016/j.nbd.2020.105211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105211</ArticleId><ArticleId IdType="pubmed">33271327</ArticleId></ArticleIdList></Reference><Reference><Citation>Makwana K., Patel S.A., Velingkaar N., Ebron J.S., Shukla G.C., Kondratov R. Aging and calorie restriction regulate the expression of miR-125a-5p and its target genes Stat3, Casp2 and Stard13. Aging. 2017;9:1825&#x2013;1843. doi: 10.18632/aging.101270.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101270</ArticleId><ArticleId IdType="pmc">PMC5559175</ArticleId><ArticleId IdType="pubmed">28783714</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Orco M., Oliver R.J., Perrone-Bizzozero N. HuD Binds to and regulates circular RNAs Derived from neuronal development- and synaptic plasticity-associated genes. Front. Genet. 2020;11:790. doi: 10.3389/fgene.2020.00790.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.00790</ArticleId><ArticleId IdType="pmc">PMC7419605</ArticleId><ArticleId IdType="pubmed">32849796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Daley E.L., Gleixner A.M., Mann J.R., Kour S., Mawrie D., Anderson E.N., Kofler J., Donnelly C.J., Kiskinis E., et al. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3. Acta Neuropathol. Commun. 2020;8:177. doi: 10.1186/s40478-020-01060-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01060-y</ArticleId><ArticleId IdType="pmc">PMC7603783</ArticleId><ArticleId IdType="pubmed">33129345</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A., Vollrath J.T., Sechi A., Johann S., Roos A., Yamoah A., Katona I., Bohlega S., Wiemuth D., Tian Y., et al. The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ. 2017;24:1655&#x2013;1671. doi: 10.1038/cdd.2017.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.88</ArticleId><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K., Droppelmann C.A., MacLellan A., Cameron I., Withers B., Campos-Melo D., Volkening K., Strong M.J. Rho guanine nucleotide exchange factor (RGNEF) is a prosurvival factor under stress conditions. Molecular Cell. Neurosci. 2017;82:88&#x2013;95. doi: 10.1016/j.mcn.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2017.05.003</ArticleId><ArticleId IdType="pubmed">28495450</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss K., Treiber T., Meister G., Schratt G. The nuclear matrix protein Matr3 regulates processing of the synaptic microRNA-138-5p. Neurobiol. Learn. Mem. 2019;159:36&#x2013;45. doi: 10.1016/j.nlm.2019.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2019.02.008</ArticleId><ArticleId IdType="pubmed">30790622</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria Lopez J.A., Gonz&#xe1;lez H.M., L&#xe9;ger G.C. Alzheimer&#x2019;s disease. Handb. Clin. Neurol. 2019;167:231&#x2013;255. doi: 10.1016/b978-0-12-804766-8.00013-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-804766-8.00013-3</ArticleId><ArticleId IdType="pubmed">31753135</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Monte S.M. Insulin resistance and Alzheimer&#x2019;s disease. BMB reports. 2009;42:475&#x2013;481. doi: 10.5483/BMBRep.2009.42.8.475.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2009.42.8.475</ArticleId><ArticleId IdType="pmc">PMC4600067</ArticleId><ArticleId IdType="pubmed">19712582</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackmann C., Hallbeck M. Oligomeric amyloid-&#x3b2; induces early and widespread changes to the proteome in human iPSC-derived neurons. Sci. Rep. 2020;10:6538. doi: 10.1038/s41598-020-63398-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-63398-6</ArticleId><ArticleId IdType="pmc">PMC7162932</ArticleId><ArticleId IdType="pubmed">32300132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de Frutos M., Gal&#xe1;n-Chilet I., Goedeke L., Kim B., Pardo-Marqu&#xe9;s V., P&#xe9;rez-Garc&#xed;a A., Herrero J.I., Fern&#xe1;ndez-Hernando C., Kim J., Ram&#xed;rez C.M. MicroRNA 7 impairs insulin signaling and regulates A&#x3b2; levels through posttranscriptional regulation of the insulin receptor substrate 2, insulin receptor, insulin-degrading enzyme, and liver x receptor pathway. Mol. Cell. Biol. 2019;39 doi: 10.1128/MCB.00170-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00170-19</ArticleId><ArticleId IdType="pmc">PMC6817752</ArticleId><ArticleId IdType="pubmed">31501273</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta U., Montalbano M., McAllen S., Minuesa G., Kharas M., Kayed R. Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2018;6:113. doi: 10.1186/s40478-018-0615-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0615-0</ArticleId><ArticleId IdType="pmc">PMC6203984</ArticleId><ArticleId IdType="pubmed">30367664</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalbano M., McAllen S., Puangmalai N., Sengupta U., Bhatt N., Johnson O.D., Kharas M.G., Kayed R. RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction. Nat. Commun. 2020;11:4305. doi: 10.1038/s41467-020-18022-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18022-6</ArticleId><ArticleId IdType="pmc">PMC7453003</ArticleId><ArticleId IdType="pubmed">32855391</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou D., Li R., Huang X., Chen G., Liu Y., Meng Y., Wang Y., Wu Y., Mao Y. Identification of molecular correlations of RBM8A with autophagy in Alzheimer&#x2019;s disease. Aging. 2019;11:11673&#x2013;11685. doi: 10.18632/aging.102571.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102571</ArticleId><ArticleId IdType="pmc">PMC6932873</ArticleId><ArticleId IdType="pubmed">31816601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Shen B., Zhang D., Wang Y., Tang Z., Ni N., Jin X., Luo M., Sun H., Gu P. miR-29a regulates the proliferation and differentiation of retinal progenitors by targeting Rbm8a. Oncotarget. 2017;8:31993&#x2013;32008. doi: 10.18632/oncotarget.16669.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.16669</ArticleId><ArticleId IdType="pmc">PMC5458264</ArticleId><ArticleId IdType="pubmed">28404883</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;bert S.S., Horr&#xe9; K., Nicola&#xef; L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer&#x2019;s disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. USA. 2008;105:6415&#x2013;6420. doi: 10.1073/pnas.0710263105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0710263105</ArticleId><ArticleId IdType="pmc">PMC2359789</ArticleId><ArticleId IdType="pubmed">18434550</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins M., Li Y., Bowser R. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases. Acta Neuropathol. Commun. 2020;8:91. doi: 10.1186/s40478-020-00965-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00965-y</ArticleId><ArticleId IdType="pmc">PMC7318465</ArticleId><ArticleId IdType="pubmed">32586379</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Aguayo V., Jim&#xe9;nez-Vacas J.M., S&#xe1;ez-Mart&#xed;nez P., G&#xf3;mez-G&#xf3;mez E., L&#xf3;pez-C&#xe1;novas J.L., Garrido-S&#xe1;nchez L., Herrera-Mart&#xed;nez A.D., Garc&#xed;a-Bermejo L., Mac&#xed;as-Gonz&#xe1;lez M., L&#xf3;pez-Miranda J., et al. Influence of Obesity in the miRNome: miR-4454, a key regulator of insulin response via splicing modulation in prostate. J. Clin. Endocrinol. Metab. 2021;106:e469&#x2013;e484. doi: 10.1210/clinem/dgaa580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa580</ArticleId><ArticleId IdType="pubmed">32841353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Lei S., Shattuck J., Boudeau S., Carlomagno Y., Medalla M., Mashimo B.L., Socorro G., Al-Mohanna L.F.A., Jiang L., et al. TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau. Proc. Natl. Acad. Sci. USA. 2021;118 doi: 10.1073/pnas.2014188118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014188118</ArticleId><ArticleId IdType="pmc">PMC7936275</ArticleId><ArticleId IdType="pubmed">33619090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues D.C., Kim D.S., Yang G., Zaslavsky K., Ha K.C., Mok R.S., Ross P.J., Zhao M., Piekna A., Wei W., et al. MECP2 Is Post-transcriptionally Regulated during Human Neurodevelopment by Combinatorial Action of RNA-Binding Proteins and miRNAs. Cell Rep. 2016;17:720&#x2013;734. doi: 10.1016/j.celrep.2016.09.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.049</ArticleId><ArticleId IdType="pubmed">27732849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Liu J., Wang Q., Jiang H., Zeng L., Li Z., Liu R. MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation via Coregulating BACE1 and PRKACB. Front. Pharmacol. 2019;10:806. doi: 10.3389/fphar.2019.00806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00806</ArticleId><ArticleId IdType="pmc">PMC6658613</ArticleId><ArticleId IdType="pubmed">31379578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q.S., Liu W., Lu G.X. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer&#x2019;s disease. J. Biosci. 2017;42:397&#x2013;404. doi: 10.1007/s12038-017-9698-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12038-017-9698-1</ArticleId><ArticleId IdType="pubmed">29358553</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox D.C., Guan X., Xia Z., Cooper T.A. Increased nuclear but not cytoplasmic activities of CELF1 protein leads to muscle wasting. Hum. Mol. Genet. 2020;29:1729&#x2013;1744. doi: 10.1093/hmg/ddaa095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa095</ArticleId><ArticleId IdType="pmc">PMC7322576</ArticleId><ArticleId IdType="pubmed">32412585</ArticleId></ArticleIdList></Reference><Reference><Citation>Saul M.J., Baumann I., Bruno A., Emmerich A.C., Wellstein J., Ottinger S.M., Contursi A., Dovizio M., Donnini S., Tacconelli S., et al. miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction. FASEB J. 2019;33:6933&#x2013;6947. doi: 10.1096/fj.201802547R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802547R</ArticleId><ArticleId IdType="pubmed">30922080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Chen X., Wang M., Zheng Z., Zhang X., Xiao Q., Peng X. Mir-206 partially rescues myogenesis deficiency by inhibiting CUGBP1 accumulation in the cell models of myotonic dystrophy. Neurol. Res. 2019;41:9&#x2013;18. doi: 10.1080/01616412.2018.1493963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2018.1493963</ArticleId><ArticleId IdType="pubmed">30281408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Thevapriya S., Kim P.J., Yu W.P., Je H.S., Tan E.K., Zeng L. Amyloid precursor protein regulates neurogenesis by antagonizing miR-574-5p in the developing cerebral cortex. Nat. Commun. 2014;5:3330. doi: 10.1038/ncomms4330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4330</ArticleId><ArticleId IdType="pubmed">24584353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.T., Chu K., Jung K.H., Kim J.H., Huh J.Y., Yoon H., Park D.K., Lim J.Y., Kim J.M., Jeon D., et al. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann. Neurol. 2012;72:269&#x2013;277. doi: 10.1002/ana.23588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23588</ArticleId><ArticleId IdType="pubmed">22926857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q., Zou L., Qian L., Zhou F., Nie H., Yu S., Jiang J., Zhuang A., Wang C., Zhang H. Expression of microRNA-222 in serum of patients with Alzheimer&#x2019;s disease. Mol. Med. Rep. 2017;16:5575&#x2013;5579. doi: 10.3892/mmr.2017.7301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7301</ArticleId><ArticleId IdType="pubmed">28849039</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L., Cui Y.H., Rao J.N., Zou T., Liu L., Smith A., Turner D.J., Gorospe M., Wang J.Y. Regulation of cyclin-dependent kinase 4 translation through CUG-binding protein 1 and microRNA-222 by polyamines. Mol. Biol. Cell. 2011;22:3055&#x2013;3069. doi: 10.1091/mbc.e11-01-0069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e11-01-0069</ArticleId><ArticleId IdType="pmc">PMC3164454</ArticleId><ArticleId IdType="pubmed">21737690</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh J. Molecular network analysis of human microRNA targetome: From cancers to Alzheimer&#x2019;s disease. BioData Min. 2012;5:17. doi: 10.1186/1756-0381-5-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0381-5-17</ArticleId><ArticleId IdType="pmc">PMC3492042</ArticleId><ArticleId IdType="pubmed">23034144</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh T., Hojo H., Suzuki T. Destabilization of microRNAs in human cells by 3&#x2019; deadenylation mediated by PARN and CUGBP1. Nucleic Acids Res. 2015;43:7521&#x2013;7534. doi: 10.1093/nar/gkv669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv669</ArticleId><ArticleId IdType="pmc">PMC4551920</ArticleId><ArticleId IdType="pubmed">26130707</ArticleId></ArticleIdList></Reference><Reference><Citation>Borreca A., Gironi K., Amadoro G., Ammassari-Teule M. Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease. Mol. Neurobiol. 2016;53:3227&#x2013;3234. doi: 10.1007/s12035-015-9229-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9229-8</ArticleId><ArticleId IdType="pubmed">26048669</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiribuzi R., Crispoltoni L., Porcellati S., Di Lullo M., Florenzano F., Pirro M., Bagaglia F., Kawarai T., Zampolini M., Orlacchio A., et al. miR128 up-regulation correlates with impaired amyloid &#x3b2;(1-42) degradation in monocytes from patients with sporadic Alzheimer&#x2019;s disease. Neurobiol. Aging. 2014;35:345&#x2013;356. doi: 10.1016/j.neurobiolaging.2013.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.08.003</ArticleId><ArticleId IdType="pubmed">24064186</ArticleId></ArticleIdList></Reference><Reference><Citation>Men Y., Ye L., Risgaard R.D., Promes V., Zhao X., Paukert M., Yang Y. Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling. Proc. Natl. Acad. Sci. USA. 2020;117:25092&#x2013;25103. doi: 10.1073/pnas.2014080117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014080117</ArticleId><ArticleId IdType="pmc">PMC7547241</ArticleId><ArticleId IdType="pubmed">32958647</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Pan L., Wei M., Wang Q., Liu W.W., Wang N., Jiang X.Y., Zhang X., Bao L. FMRP-Mediated Axonal Delivery of miR-181d Regulates Axon Elongation by Locally Targeting Map1b and Calm1. Cell Rep. 2015;13:2794&#x2013;2807. doi: 10.1016/j.celrep.2015.11.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.11.057</ArticleId><ArticleId IdType="pubmed">26711345</ArticleId></ArticleIdList></Reference><Reference><Citation>Indrieri A., Carrella S., Carotenuto P., Banfi S., Franco B. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer. Int. J. Mol. Sci. 2020;21:2092. doi: 10.3390/ijms21062092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21062092</ArticleId><ArticleId IdType="pmc">PMC7139714</ArticleId><ArticleId IdType="pubmed">32197476</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D., Neilson J.R., Foster K.A., Wang C.F., Seeburg D.P., Batterton M.N., Tada T., Dolan B.M., Sharp P.A., Sheng M. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron. 2010;65:373&#x2013;384. doi: 10.1016/j.neuron.2010.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.01.005</ArticleId><ArticleId IdType="pmc">PMC5018398</ArticleId><ArticleId IdType="pubmed">20159450</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Tu Q., Liu M. MicroRNA-125b regulates Alzheimer&#x2019;s disease through SphK1 regulation. Mol. Med. Rep. 2018;18:2373&#x2013;2380. doi: 10.3892/mmr.2018.9156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2018.9156</ArticleId><ArticleId IdType="pubmed">29901156</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha D.J., Mengel D., Mustapic M., Liu W., Selkoe D.J., Kapogiannis D., Galasko D., Rissman R.A., Bennett D.A., Walsh D.M. miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of alzheimer&#x2019;s patients. Front. Neurosci. 2019;13:1208. doi: 10.3389/fnins.2019.01208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01208</ArticleId><ArticleId IdType="pmc">PMC6902042</ArticleId><ArticleId IdType="pubmed">31849573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Mang G., Wu J., Sun P., Li T., Zhang H., Wang N., Tong Z., Wang W., Zheng Y., et al. Circular RNA circSnx5 controls immunogenicity of dendritic cells through the miR-544/SOCS1 Axis and PU.1 activity regulation. Mol. Ther. 2020;28:2503&#x2013;2518. doi: 10.1016/j.ymthe.2020.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2020.07.001</ArticleId><ArticleId IdType="pmc">PMC7646215</ArticleId><ArticleId IdType="pubmed">32681834</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Espejo S., Santos-Zorrozua B., Alvarez-Gonzalez P., Martin-Guerrero I., Garcia-Orad A., Lopez-Lopez E. A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2021;58:55&#x2013;64. doi: 10.1007/s12035-020-02103-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02103-0</ArticleId><ArticleId IdType="pubmed">32892277</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun Y., Zhang Y., Zhang C., Huang L., Tan S., Wang P., Vilari&#xf1;o-G&#xfa;ell C., Song W., Sun X. Regulator of calcineurin 1 is a novel RNA-binding protein to regulate neuronal apoptosis. Mol. Psychiatry. 2019 doi: 10.1038/s41380-019-0487-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0487-0</ArticleId><ArticleId IdType="pubmed">31451750</ArticleId></ArticleIdList></Reference><Reference><Citation>Eissa S., Safwat M., Matboli M., Zaghloul A., El-Sawalhi M., Shaheen A. Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer. Urol. Oncol. 2019;37:292. doi: 10.1016/j.urolonc.2018.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2018.12.024</ArticleId><ArticleId IdType="pubmed">30654976</ArticleId></ArticleIdList></Reference><Reference><Citation>Maziuk B.F., Apicco D.J., Cruz A.L., Jiang L., Ash P.E.A., da Rocha E.L., Zhang C., Yu W.H., Leszyk J., Abisambra J.F., et al. RNA binding proteins co-localize with small tau inclusions in tauopathy. Acta Neuropathol. Commun. 2018;6:71. doi: 10.1186/s40478-018-0574-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0574-5</ArticleId><ArticleId IdType="pmc">PMC6069705</ArticleId><ArticleId IdType="pubmed">30068389</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Nguyen P.T., Shim H.S., Hyeon S.J., Im H., Choi M.H., Chung S., Kowall N.W., Lee S.B., Ryu H. EWSR1, a multifunctional protein, regulates cellular function and aging via genetic and epigenetic pathways. Biochim. Biophys. Acta Mol. Basis Dis. 2019;1865:1938&#x2013;1945. doi: 10.1016/j.bbadis.2018.10.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.10.042</ArticleId><ArticleId IdType="pmc">PMC6527469</ArticleId><ArticleId IdType="pubmed">30481590</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kang Y.S., Lee N.Y., Kim K.Y., Hwang Y.J., Kim H.W., Rhyu I.J., Her S., Jung M.K., Kim S., et al. Uvrag targeting by Mir125a and Mir351 modulates autophagy associated with Ewsr1 deficiency. Autophagy. 2015;11:796&#x2013;811. doi: 10.1080/15548627.2015.1035503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1035503</ArticleId><ArticleId IdType="pmc">PMC4509448</ArticleId><ArticleId IdType="pubmed">25946189</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaraj S., Zoltowska K.M., Laskowska-Kaszub K., Wojda U. microRNA diagnostic panel for Alzheimer&#x2019;s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res. Rev. 2019;49:125&#x2013;143. doi: 10.1016/j.arr.2018.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2018.10.008</ArticleId><ArticleId IdType="pubmed">30391753</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo H.N., Park S., Kim H.L., Jung M.K., Pack C.G., Park J., Cho Y., Jo D.G., Kim D.K., Mook-Jung I., et al. miR-351-5p/Miro2 axis contributes to hippocampal neural progenitor cell death via unbalanced mitochondrial fission. Molecular therapy. Nucleic Acids. 2021;23:643&#x2013;656. doi: 10.1016/j.omtn.2020.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2020.12.014</ArticleId><ArticleId IdType="pmc">PMC7848773</ArticleId><ArticleId IdType="pubmed">33575111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Li L., Qiu X., Wu J., Xu L., Shao W. Long non-coding RNA ANRIL knockdown suppresses apoptosis and pro-inflammatory cytokines while enhancing neurite outgrowth via binding microRNA-125a in a cellular model of Alzheimer&#x2019;s disease. Mol. Med. Rep. 2020;22:1489&#x2013;1497. doi: 10.3892/mmr.2020.11203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11203</ArticleId><ArticleId IdType="pmc">PMC7339647</ArticleId><ArticleId IdType="pubmed">32626959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishof I., Dammer E.B., Duong D.M., Kundinger S.R., Gearing M., Lah J.J., Levey A.I., Seyfried N.T. RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer&#x2019;s disease. J. Biol. Chem. 2018;293:11047&#x2013;11066. doi: 10.1074/jbc.RA118.001747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.001747</ArticleId><ArticleId IdType="pmc">PMC6052236</ArticleId><ArticleId IdType="pubmed">29802200</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalbano M., McAllen S., Cascio F.L., Sengupta U., Garcia S., Bhatt N., Ellsworth A., Heidelman E.A., Johnson O.D., Doskocil S., et al. TDP-43 and Tau Oligomers in Alzheimer&#x2019;s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. Neurobiol. Dis. 2020;146:105130. doi: 10.1016/j.nbd.2020.105130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105130</ArticleId><ArticleId IdType="pmc">PMC7703712</ArticleId><ArticleId IdType="pubmed">33065281</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., De Conti L., Stuani C., Romano M., Baralle M., Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277:2268&#x2013;2281. doi: 10.1111/j.1742-4658.2010.07643.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07643.x</ArticleId><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano-Crespo M., Atienza M., Cantero J.L. Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1-40 and cerebral vulnerability in normal aging. Transl. Neurodegener. 2019;8:34. doi: 10.1186/s40035-019-0174-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-019-0174-8</ArticleId><ArticleId IdType="pmc">PMC6827222</ArticleId><ArticleId IdType="pubmed">31700619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C., Lau P., Salta E., Tournoy J., Bossers K., Vandenberghe R., Wallin A., Bjerke M., Zetterberg H., Blennow K., et al. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurology. 2013;81:2103&#x2013;2106. doi: 10.1212/01.wnl.0000437306.37850.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000437306.37850.22</ArticleId><ArticleId IdType="pubmed">24212398</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti T., Terzakis K. Parkinson Disease. Home Healthc. Now. 2016;34:300&#x2013;307. doi: 10.1097/NHH.0000000000000398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NHH.0000000000000398</ArticleId><ArticleId IdType="pubmed">27243427</ArticleId></ArticleIdList></Reference><Reference><Citation>Emamzadeh F.N., Surguchov A. Parkinson&#x2019;s Disease: Biomarkers, Treatment, and Risk Factors. Front. Neurosci. 2018;12:612. doi: 10.3389/fnins.2018.00612.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00612</ArticleId><ArticleId IdType="pmc">PMC6125353</ArticleId><ArticleId IdType="pubmed">30214392</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Brug M.P., Blackinton J., Chandran J., Hao L.Y., Lal A., Mazan-Mamczarz K., Martindale J., Xie C., Ahmad R., Thomas K.J., et al. RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc. Natl. Acad. Sci. USA. 2008;105:10244&#x2013;10249. doi: 10.1073/pnas.0708518105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0708518105</ArticleId><ArticleId IdType="pmc">PMC2481328</ArticleId><ArticleId IdType="pubmed">18626009</ArticleId></ArticleIdList></Reference><Reference><Citation>Repici M., Hassanjani M., Maddison D.C., Gar&#xe7;&#xe3;o P., Cimini S., Patel B., Szeg&#xf6; &#xc9;.M., Straatman K.R., Lilley K.S., Borsello T., et al. The Parkinson&#x2019;s Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration. Mol. Neurobiol. 2019;56:61&#x2013;77. doi: 10.1007/s12035-018-1084-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1084-y</ArticleId><ArticleId IdType="pmc">PMC6334738</ArticleId><ArticleId IdType="pubmed">29675578</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.E., Park H.J., He L., Skibiel C., Junn E., Mouradian M.M. The Parkinson&#x2019;s disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress. Redox Biol. 2018;19:62&#x2013;73. doi: 10.1016/j.redox.2018.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.07.021</ArticleId><ArticleId IdType="pmc">PMC6092527</ArticleId><ArticleId IdType="pubmed">30107296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W., Li Y., Wang C., Xu F., Wang M., Liu Y. Serum miR-221 serves as a biomarker for Parkinson&#x2019;s disease. Cell Biochem. Funct. 2016;34:511&#x2013;515. doi: 10.1002/cbf.3224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3224</ArticleId><ArticleId IdType="pubmed">27748571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Jou I., Joe E.H. Suppression of miR-155 Expression in IFN-&#x3b3;-treated astrocytes and microglia by DJ-1: A Possible mechanism for maintaining SOCS1 expression. Exp. Neurobiol. 2014;23:148&#x2013;154. doi: 10.5607/en.2014.23.2.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2014.23.2.148</ArticleId><ArticleId IdType="pmc">PMC4065828</ArticleId><ArticleId IdType="pubmed">24963279</ArticleId></ArticleIdList></Reference><Reference><Citation>Thome A.D., Harms A.S., Volpicelli-Daley L.A., Standaert D.G. microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. J. Neurosci. 2016;36:2383&#x2013;2390. doi: 10.1523/JNEUROSCI.3900-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3900-15.2016</ArticleId><ArticleId IdType="pmc">PMC4764660</ArticleId><ArticleId IdType="pubmed">26911687</ArticleId></ArticleIdList></Reference><Reference><Citation>Noureddine M.A., Qin X.J., Oliveira S.A., Skelly T.J., van der Walt J., Hauser M.A., Pericak-Vance M.A., Vance J.M., Li Y.J. Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum. Genet. 2005;117:27&#x2013;33. doi: 10.1007/s00439-005-1259-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-005-1259-2</ArticleId><ArticleId IdType="pubmed">15827745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C., Jeong D.E., Heo S., Ji E., Rho J.G., Jung M., Ahn S., Kim Y.J., Kim Y.S., Nam S.W., et al. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27(Kip1) levels and poor prognosis. J. Pathol. 2018;246:231&#x2013;243. doi: 10.1002/path.5135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5135</ArticleId><ArticleId IdType="pmc">PMC6150781</ArticleId><ArticleId IdType="pubmed">30014466</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh S.Y., Chao Y.X., Dheen S.T., Tan E.K., Tay S.S. Role of MicroRNAs in parkinson&#x2019;s disease. Int. J. Mol. Sci. 2019;20:5649. doi: 10.3390/ijms20225649.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20225649</ArticleId><ArticleId IdType="pmc">PMC6888719</ArticleId><ArticleId IdType="pubmed">31718095</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Zhang H., Xie L., Qian C., Ye Y., Mao H., Wang B., Zhang H., Zhang Y., He X., et al. Tristetraprolin destabilizes NOX2 mRNA and protects dopaminergic neurons from oxidative damage in Parkinson&#x2019;s disease. FASEB J. 2020;34:15047&#x2013;15061. doi: 10.1096/fj.201902967R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201902967R</ArticleId><ArticleId IdType="pubmed">32954540</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W., Li W., Hoque M., Li Z., Tian B., Makeyev E.V. A post-transcriptional mechanism pacing expression of neural genes with precursor cell differentiation status. Nat. Commun. 2015;6:7576. doi: 10.1038/ncomms8576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8576</ArticleId><ArticleId IdType="pmc">PMC4506538</ArticleId><ArticleId IdType="pubmed">26144867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Sun L., Jia K., Wang H., Wang X. miR-9-5p modulates the progression of Parkinson&#x2019;s disease by targeting SIRT1. Neurosci. Lett. 2019;701:226&#x2013;233. doi: 10.1016/j.neulet.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.02.038</ArticleId><ArticleId IdType="pubmed">30826419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyant K.J., Ridder A.J., Dayalu P. Huntington&#x2019;s disease-update on treatments. Curr. Neurol. Neurosci. Rep. 2017;17:33. doi: 10.1007/s11910-017-0739-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-017-0739-9</ArticleId><ArticleId IdType="pubmed">28324302</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis M.Y., Keene C.D., Jayadev S., Bird T. The co-occurrence of Alzheimer&#x2019;s disease and Huntington&#x2019;s disease: A neuropathological study of 15 elderly Huntington&#x2019;s disease subjects. J. Huntingt. Dis. 2014;3:209&#x2013;217. doi: 10.3233/JHD-140111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JHD-140111</ArticleId><ArticleId IdType="pubmed">25062863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez I.H., Cabrera J.R., Santos-Galindo M., S&#xe1;nchez-Mart&#xed;n M., Dom&#xed;nguez V., Garc&#xed;a-Escudero R., P&#xe9;rez-&#xc1;lvarez M.J., Pintado B., Lucas J.J. Pathogenic SREK1 decrease in Huntington&#x2019;s disease lowers TAF1 mimicking X-linked dystonia parkinsonism. Brain. 2020;143:2207&#x2013;2219. doi: 10.1093/brain/awaa150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa150</ArticleId><ArticleId IdType="pmc">PMC7363496</ArticleId><ArticleId IdType="pubmed">32533168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Wu P., Yang Z., Deng S., Ni L., Zhang Y., Jin L., Pan Y. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1. Am. J. Cancer Res. 2020;10:38&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017744</ArticleId><ArticleId IdType="pubmed">32064152</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro T.D.S., Sorrentino J.M., Salvador S., Veit T., Souza D.O., de Almeida R.F. Alterations in the MicroRNA of the Blood of Autism Spectrum Disorder Patients: Effects on Epigenetic Regulation and Potential Biomarkers. Behav. Sci. 2018;8:75. doi: 10.3390/bs8080075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bs8080075</ArticleId><ArticleId IdType="pmc">PMC6115946</ArticleId><ArticleId IdType="pubmed">30111726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin N., Chang K.Y., Li Z., Gates K., Rana Z.A., Dang J., Zhang D., Han T., Yang C.S., Cunningham T.J., et al. An evolutionarily conserved long noncoding RNA TUNA controls pluripotency and neural lineage commitment. Mol. Cell. 2014;53:1005&#x2013;1019. doi: 10.1016/j.molcel.2014.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.01.021</ArticleId><ArticleId IdType="pmc">PMC4010157</ArticleId><ArticleId IdType="pubmed">24530304</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Shen S., Ruan X., Liu X., Zheng J., Liu Y., Yang C., Wang D., Liu L., Ma J., et al. Biosynthetic CircRNA_001160 induced by PTBP1 regulates the permeability of BTB via the CircRNA_001160/miR-195-5p/ETV1 axis. Cell Death Dis. 2019;10:960. doi: 10.1038/s41419-019-2191-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-2191-z</ArticleId><ArticleId IdType="pmc">PMC6925104</ArticleId><ArticleId IdType="pubmed">31862871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Zhang X., Wang J., Di F., Xue Y., Lin X., Zhang Y., Zhang H., Zhang Z., Gu Y. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway. FASEB J. 2020;34:9941&#x2013;9958. doi: 10.1096/fj.202000045R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000045R</ArticleId><ArticleId IdType="pubmed">32623796</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Huang M., Guo L., Zhu L., Hou J., Zhang L., Pero A., Ng S., El Gaamouch F., Elder G., et al. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer&#x2019;s disease pathogenesis. Mol. Psychiatry. 2020 doi: 10.1038/s41380-020-0824-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0824-3</ArticleId><ArticleId IdType="pmc">PMC7785685</ArticleId><ArticleId IdType="pubmed">32632205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai J., Sun L.H., Che H., Zhang R., Zhang T.Z., Wu W.C., Su X.L., Chen X., Yang G., Li K., et al. MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J. Neurosci. 2013;33:3989&#x2013;4001. doi: 10.1523/JNEUROSCI.1997-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1997-12.2013</ArticleId><ArticleId IdType="pmc">PMC6619292</ArticleId><ArticleId IdType="pubmed">23447608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Yoon H., Chung D.E., Brown J.L., Belmonte K.C., Kim J. miR-186 is decreased in aged brain and suppresses BACE1 expression. J. Neurochem. 2016;137:436&#x2013;445. doi: 10.1111/jnc.13507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13507</ArticleId><ArticleId IdType="pmc">PMC4837067</ArticleId><ArticleId IdType="pubmed">26710318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H., Sun M., Wang Z.L., Wu Q., Yao J., Ren G., Sun X.L. LncRNA RMST-mediated miR-107 transcription promotes OGD-induced neuronal apoptosis via interacting with hnRNPK. Neurochem. Int. 2020;133:104644. doi: 10.1016/j.neuint.2019.104644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.104644</ArticleId><ArticleId IdType="pubmed">31852624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Wang W.X. MiR-107 is reduced in Alzheimer&#x2019;s disease brain neocortex: Validation study. J. Alzheimer&#x2019;s Dis. JAD. 2010;21:75&#x2013;79. doi: 10.3233/JAD-2010-091603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-091603</ArticleId><ArticleId IdType="pmc">PMC2910235</ArticleId><ArticleId IdType="pubmed">20413881</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q., Li C., Yu M., Sun Y., Wang J., Ma L., Sun X., Lu B. HuR stabilizes HTT mRNA via interacting with its exon 11 in a mutant HTT-dependent manner. RNA Biol. 2020;17:500&#x2013;516. doi: 10.1080/15476286.2020.1712894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1712894</ArticleId><ArticleId IdType="pmc">PMC7237150</ArticleId><ArticleId IdType="pubmed">31928144</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner N., Kemp K.C., Scott H.L., Shi G., Rivers C., Gialeli A., Wong L.F., Cordero L.O., Allen N., Wilkins A., et al. Abnormal scaffold attachment factor 1 expression and localization in spinocerebellar ataxias and Huntington&#x2019;s chorea. Brain Pathol. 2020;30:1041&#x2013;1055. doi: 10.1111/bpa.12872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12872</ArticleId><ArticleId IdType="pmc">PMC8018166</ArticleId><ArticleId IdType="pubmed">32580238</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers C., Idris J., Scott H., Rogers M., Lee Y.B., Gaunt J., Phylactou L., Curk T., Campbell C., Ule J., et al. iCLIP identifies novel roles for SAFB1 in regulating RNA processing and neuronal function. BMC Biol. 2015;13:111. doi: 10.1186/s12915-015-0220-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-015-0220-7</ArticleId><ArticleId IdType="pmc">PMC4689037</ArticleId><ArticleId IdType="pubmed">26694817</ArticleId></ArticleIdList></Reference><Reference><Citation>Das E., Jana N.R., Bhattacharyya N.P. Delayed Cell Cycle Progression in STHdh(Q111)/Hdh(Q111) Cells, a Cell Model for Huntington&#x2019;s Disease Mediated by microRNA-19a, microRNA-146a and microRNA-432. MicroRNA. 2015;4:86&#x2013;100. doi: 10.2174/2211536604666150713105606.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2211536604666150713105606</ArticleId><ArticleId IdType="pubmed">26165466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita C., Kikuchi-Utsumi K., Aoyama K., Suzuki R., Okamoto Y., Matsumura N., Omata D., Maruyama K., Nakaki T. Inhibition of miR-96-5p in the mouse brain increases glutathione levels by altering NOVA1 expression. Commun. Biol. 2021;4:182. doi: 10.1038/s42003-021-01706-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01706-0</ArticleId><ArticleId IdType="pmc">PMC7876013</ArticleId><ArticleId IdType="pubmed">33568779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubhi K., Rockenstein E., Kragh C., Inglis C., Spencer B., Michael S., Mante M., Adame A., Galasko D., Masliah E. Widespread microRNA dysregulation in multiple system atrophy&#x2014;Disease-related alteration in miR-96. Eur. J. Neurosci. 2014;39:1026&#x2013;1041. doi: 10.1111/ejn.12444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.12444</ArticleId><ArticleId IdType="pmc">PMC4052839</ArticleId><ArticleId IdType="pubmed">24304186</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli A., Stankovic I., Krismer F., Seppi K., Levin J., Wenning G.K. Multiple system atrophy. Int. Rev. Neurobiol. 2019;149:137&#x2013;192. doi: 10.1016/bs.irn.2019.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.irn.2019.10.004</ArticleId><ArticleId IdType="pubmed">31779811</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama K., Wang F., Matsumura N., Kiyonari H., Shioi G., Tanaka K., Kinoshita C., Kikuchi-Utsumi K., Watabe M., Nakaki T. Increased neuronal glutathione and neuroprotection in GTRAP3-18-deficient mice. Neurobiol. Dis. 2012;45:973&#x2013;982. doi: 10.1016/j.nbd.2011.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.016</ArticleId><ArticleId IdType="pubmed">22210510</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Garc&#xed;a L., L&#xf3;pez-Royo T., Calvo A.C., Toivonen J.M., de la Torre M., Moreno-Mart&#xed;nez L., Molina N., Aparicio P., Zaragoza P., Manzano R., et al. Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases. Int. J. Mol. Sci. 2020;21:9582. doi: 10.3390/ijms21249582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249582</ArticleId><ArticleId IdType="pmc">PMC7765627</ArticleId><ArticleId IdType="pubmed">33339180</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>